Journal Article Improving the value and interpretation of observational studies comparing treatment effects of osteoporosis medications depends on standardized reporting of methods Get access Kaleen N Hayes, Kaleen N Hayes Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI 02903, United StatesCenter of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI 02908, United States Corresponding author: Kaleen (Kaley) N. Hayes, Department of Health Services, Policy, and Practice, Brown University School of Public Health, 121 South Main Street, Providence, Rhode Island, United States (Kaley_hayes@brown.edu). Search for other works by this author on: Oxford Academic Google Scholar Arman Oganisian, Arman Oganisian Department of Biostatistics, Brown University School of Public Health, Providence, RI 02903, United States Search for other works by this author on: Oxford Academic Google Scholar Douglas P Kiel Douglas P Kiel Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA 02131, United StatesDepartment of Medicine, Harvard Medical School, Boston, MA 02115, United StatesDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, United States https://orcid.org/0000-0001-8474-0310 Search for other works by this author on: Oxford Academic Google Scholar Journal of Bone and Mineral Research, Volume 39, Issue 7, July 2024, Pages 807–809, https://doi.org/10.1093/jbmr/zjae099 Published: 27 July 2024 Article history Received: 14 May 2024 Revision received: 04 June 2024 Accepted: 01 July 2024 Published: 27 July 2024
No takes yet. Share an insight, caveat, or question.
Hayes et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: